SCENESSE® (afamelanotide) implant is a prescription medication indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP).
It is available through our accredited EPP centers where specialists trained in the administration of SCENESSE® treat patients. If you have a patient in your care who could benefit from this treatment, please reach out to us in the first instance and we can connect you with the nearest treating specialist.
Please note that SCENESSE® is not suitable for patients involved in clinical trials for other EPP treatments.